[THE INVESTOR]
Hanmi Pharm announced on July 4 that it has founded a 10 billion won (US$ 8.7 million) investment company that will invest in biotech and pharmaceutical fields.
The new company, named Hanmi Ventures, will be headed by Hanmi IT CEO Lim Jong-hoon, and the capital was raised from Hanmi Pharm chairman Lim Sung-ki and the company’s affiliates.
Hanmi Ventures plans to initially focus on investing in pharmaceutical and biotech related fields, and Hanmi Science and Hanmi Pharm will take over investing in SMEs once a compound is close to commercial use.
By Choi He-suk (
cheesuk@heraldcorp.com)
